RELAPSED OR REFRACTORY LYMPHOBLASTIC LYMPHOMA

Clinical trials for RELAPSED OR REFRACTORY LYMPHOBLASTIC LYMPHOMA explained in plain language.

Never miss a new study

Get alerted when new RELAPSED OR REFRACTORY LYMPHOBLASTIC LYMPHOMA trials appear

Sign up with your email to follow new studies for RELAPSED OR REFRACTORY LYMPHOBLASTIC LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Completed 1

Engineered immune cells take on tough blood cancers

Disease control Not yet recruiting

This early-stage trial tests a personalized cell therapy called CD19/22 CAR-T cells in 17 adults with relapsed or refractory acute lymphoblastic leukemia or B-cell lymphoma. Patients receive their own immune cells that have been reprogrammed to target and kill cancer cells. The s…

Matched conditions: RELAPSED OR REFRACTORY LYMPHOBLASTIC LYMPHOMA

Phase: PHASE1, PHASE2 • Sponsor: Minsk Scientific-Practical Center for Surgery, Transplantation and Hematology • Aim: Disease control

Last updated Jun 26, 2026 14:45 UTC

RELAPSED OR REFRACTORY LYMPHOBLASTIC LYMPHOMA

Get alerted when new RELAPSED OR REFRACTORY LYMPHOBLASTIC LYMPHOMA trials appear

Engineered immune cells take on tough blood cancers